Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection
about
Structural basis for functional tetramerization of lentiviral integraseLocalization of ASV integrase-DNA contacts by site-directed crosslinking and their structural analysisBiochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase.Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase.Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds.Division of labor within human immunodeficiency virus integrase complexes: determinants of catalysis and target DNA captureMetal binding by the D,DX35E motif of human immunodeficiency virus type 1 integrase: selective rescue of Cys substitutions by Mn2+ in vitroRetroviral Integrase Structure and DNA Recombination MechanismAn amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.Molecular and genetic determinants of rous sarcoma virus integrase for concerted DNA integration.HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.Design, Synthesis, and Biological Evaluation of 1,2-Dihydroisoquinolines as HIV-1 Integrase Inhibitors.Alternative nucleophilic substrates for the endonuclease activities of human immunodeficiency virus type 1 integraseStructural biology of retroviral DNA integration.Sites of retroviral DNA integration: From basic research to clinical applicationspiggyBac transposase tools for genome engineeringIntegrase residues that determine nucleotide preferences at sites of HIV-1 integration: implications for the mechanism of target DNA binding.HIV-1 Integrase-DNA Recognition Mechanisms.Role of the nonspecific DNA-binding region and alpha helices within the core domain of retroviral integrase in selecting target DNA sites for integration.Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase {alpha}4 helix.A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase.Defining the DNA substrate binding sites on HIV-1 integrase.Integration specificity of LTR-retrotransposons and retroviruses in the Drosophila melanogaster genome.
P2860
Q27316560-8C297081-81A6-4DE3-B910-66861C42EEF0Q28478206-9FC3FC14-B77E-4045-96B3-B906A1A7E389Q30157084-034CB607-4394-4464-9933-C71692858C93Q33782016-F250A1EE-7E56-44EE-AB9E-B0D81990BA0AQ34044741-DFCA170E-A58C-4E70-8D95-49DD108B6800Q34228616-F207D93C-D56A-4D9E-ADAD-0F4CEECBD479Q34437364-8B7BB73C-3956-45FF-A2BF-12E096D853B7Q34668065-22010DE1-C997-4359-A8AB-873919D668A9Q34743380-6CDFFAAA-3B36-46F9-B62A-71F7EFE15283Q34997039-CAC0F19A-1C36-42DF-A334-0BAE42F15CA2Q35134947-AC7294CE-BAB6-4EDC-AC16-06D80361AC83Q36146699-D952D4FF-A1DD-4D24-B36C-8D1CB026C9BBQ36240626-E0DF2D79-9E02-4A16-AB1F-3DFFA29F6521Q36806748-D0511F6F-E6B6-482D-9ECA-AE9010234A7DQ36900663-5697D9FE-8F51-410B-B8B6-817B69D6CBD2Q36950347-05DEC406-328B-4571-A74A-1DD701B0E318Q37734406-2B539930-7181-4302-8AB3-25A7CB8D32E7Q37945176-7253E3AB-8A72-43DD-857A-532DE33FB3E6Q38296174-7372BEF2-F25E-478C-ACD4-975DDB5505FDQ38349833-5E2170F0-66AE-4609-B260-70CA99080998Q42026855-AD90CDBA-A07B-4EEB-A9F5-C9893E53CA78Q42091632-85C1FC5F-00FC-4EBB-9A30-5A9890D19B1CQ42642514-8D02AC9E-7840-4842-B53A-64361AAAC8B9Q42692906-96529E6F-CF79-4877-93FA-7616C737AEB2
P2860
Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Use of patient-derived human i ...... affects target site selection
@ast
Use of patient-derived human i ...... affects target site selection
@en
type
label
Use of patient-derived human i ...... affects target site selection
@ast
Use of patient-derived human i ...... affects target site selection
@en
prefLabel
Use of patient-derived human i ...... affects target site selection
@ast
Use of patient-derived human i ...... affects target site selection
@en
P2093
P2860
P1433
P1476
Use of patient-derived human i ...... affects target site selection
@en
P2093
P2860
P304
P356
10.1128/JVI.75.16.7756-7762.2001
P577
2001-08-01T00:00:00Z